Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $50.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 2547300.0% year-over-year to $50.9 million; the TTM figure through Mar 2026 stood at $50.9 million (up 2547300.0% YoY), while the FY2025 annual figure was $44.8 million, changed N/A from the prior year.
• Other Non-Current Liabilities came in at $50.9 million for Q1 2026 at Camp4 Therapeutics, up from $44.8 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $50.9 million in Q1 2026 to a low of $2000.0 in Q4 2023.
• A 4-year average of $16.1 million and a median of $2000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities soared 836500.0% in 2025 and soared 2547300.0% in 2026, its largest moves.
• Camp4 Therapeutics' Other Non-Current Liabilities stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then jumped by 2237900.0% to $44.8 million in 2025, then gained by 13.82% to $50.9 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $50.9 million, $44.8 million, and $16.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison